Delivery of therapeutic oligonucleotides with cell penetrating peptides.

Authors:
Boisguérin P; Deshayes S; Gait MJ; O'Donovan L; Godfrey C and 3 more

Journal:
Adv Drug Deliv Rev

Publication Year: 2015

DOI:
10.1016/j.addr.2015.02.008

PMCID:
PMC7102600

PMID:
25747758

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Adv Drug Deliv Rev

Abbreviation: Adv Drug Deliv Rev

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Drug Therapy

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Advancements of in vitro transcribed mRNA (IVT mRNA) to enable translation into the clinics.
Kang DD; Li H; Dong Y. (2023) - Transparency Score: 3/6
Advances in mRNA therapeutics for cancer immunotherapy: From modification to delivery.
Han G; Noh D; Lee H and 4 more (2023) - Transparency Score: 3/6
Imaging drug delivery to the lungs: Methods and applications in oncology.
Man F; Tang J; Swedrowska M and 2 more (2022) - Transparency Score: 3/6
In vivo fate and intracellular trafficking of vaccine delivery systems.
Lee J; Kim D; Byun J and 3 more (2022) - Transparency Score: 3/6
Monocytes as a convergent nanoparticle therapeutic target for cardiovascular diseases.
Aldarondo D; Wayne E. (2022) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
1/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:

"LO'D was supported by a grant from the French muscular dystrophy association AFM (programme number 14784). The work in the laboratory of MJG was supported by the Medical Research Council (MRC programme number U105178803). BL and MJAW were supported by the AFM grant “Advances in oligonucleotide-mediated exon skipping for DMD and related disorders”. Work in the laboratory of PB and SD was partly funded by the FEDER (Fonds Européen de Développement Regional)/La Région Languedoc-Roussillon, by the Agence Nationale de la Recherche (ANR) and by the Centre National de la Recherche Scientifique (CNRS)."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025